Compositions And Methods For Enhancing Coagulation Factor Viii Function

Patent No. EP2482841 (titled "Compositions And Methods For Enhancing Coagulation Factor Viii Function") was filed by The Childrens Hospital OF Philadelphia on Oct 4, 2010. The application was issued on Sep 28, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BIOVERATIV THERAPEUTICSAug 21, 2019ZWICKER
FH SERVICESAug 21, 2019LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB
STRAWMANAug 16, 2019GILL

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2482841

THE CHILDRENS HOSPITAL OF PHILADELPHIA
Application Number
EP10821393A
Filing Date
Oct 4, 2010
Status
Patent Maintained As Amended
Aug 26, 2022
Publication Date
Sep 28, 2022